Timing and duration of anti–α4β1 integrin treatment after spinal cord injury: effect on therapeutic efficacy
Jennifer C. Fleming(Western University), Lynne C. Weaver(Robarts Clinical Trials), Laura E. González-Lara(Western University), Eilis F. Hamilton(Robarts Clinical Trials), Paula J. Foster(Western University), Yuhua Chen(Xi'an Peihua University), Feng Bao(Robarts Clinical Trials)
Cited by 27
Related Papers
Transient Blockade of the CD11d/CD18 Integrin Reduces Secondary Damage after Spinal Cord Injury, Improving Sensory, Autonomic, and Motor Function
|Journal of Neuroscience|2004|319
Effects of post-weld heat treatment on the microstructure and mechanical properties of laser-welded NiTi/304SS joint with Ni filler
|Materials Science and Engineering A|2019|272
Ablation of caspase-1 protects against TBI-induced pyroptosis in vitro and in vivo
|Journal of Neuroinflammation|2018|191
Early anti‐inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats
|Journal of Neurochemistry|2004|159